Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-viral nano-immunotherapeutics targeting tumor microenvironmental immune cells
Seok‐Beom Yong, Jee Young Chung, Yoonsung Song, et al.
Biomaterials (2019) Vol. 219, pp. 119401-119401
Closed Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Exosomes: key players in cancer and potential therapeutic strategy
Jie Dai, Yangzhou Su, Suye Zhong, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 902
Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance
Wei Wu, Jessica Klockow, Michael Zhang, et al.
Pharmacological Research (2021) Vol. 171, pp. 105780-105780
Open Access | Times Cited: 454
The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy
Qiyao Yang, Ningning Guo, Yi Zhou, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 10, Iss. 11, pp. 2156-2170
Open Access | Times Cited: 311
ZIF‐8 Nanoparticles Evoke Pyroptosis for High‐Efficiency Cancer Immunotherapy
Binbin Ding, Hao Chen, Jia Tan, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 10
Closed Access | Times Cited: 193
Oncolytic mineralized bacteria as potent locally administered immunotherapeutics
Chenya Wang, Liping Zhong, Jiachen Xu, et al.
Nature Biomedical Engineering (2024) Vol. 8, Iss. 5, pp. 561-578
Closed Access | Times Cited: 43
CAR-T cell therapy: developments, challenges and expanded applications from cancer to autoimmunity
Yaxian Kong, Jingyao Li, Xia Zhao, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 3
Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts
Zhongsong Zhang, Long Chen
Cancer Nanotechnology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Imidazole‐Based Synthetic Lipidoids for In Vivo mRNA Delivery into Primary T Lymphocytes
Xuewei Zhao, Jinjin Chen, Min Qiu, et al.
Angewandte Chemie International Edition (2020) Vol. 59, Iss. 45, pp. 20083-20089
Closed Access | Times Cited: 127
Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review
Bo Hu, Jianzhen Lin, Xiaobo Yang, et al.
Cell Proliferation (2020) Vol. 53, Iss. 3
Open Access | Times Cited: 108
Nanobody: A Small Antibody with Big Implications for Tumor Therapeutic Strategy
Shuyang Sun, Ziqiang Ding, Xiaomei Yang, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 2337-2356
Open Access | Times Cited: 94
Nano-Therapies for Glioblastoma Treatment
Edouard Alphandéry
Cancers (2020) Vol. 12, Iss. 1, pp. 242-242
Open Access | Times Cited: 89
Dawn of lipid nanoparticles in lymph node targeting: Potential in cancer immunotherapy
Takashi Nakamura, Hideyoshi Harashima
Advanced Drug Delivery Reviews (2020) Vol. 167, pp. 78-88
Closed Access | Times Cited: 87
Improving the ability of CAR-T cells to hit solid tumors: Challenges and strategies
Zhengzheng Zhang, Tian Wang, Xiaofeng Wang, et al.
Pharmacological Research (2021) Vol. 175, pp. 106036-106036
Open Access | Times Cited: 70
Dual‐Targeted Lipid Nanotherapeutic Boost for Chemo‐Immunotherapy of Cancer
Seok‐Beom Yong, Srinivas Ramishetti, Meir Goldsmith, et al.
Advanced Materials (2022) Vol. 34, Iss. 13
Open Access | Times Cited: 44
Nanoparticle‐Mediated STING Activation for Cancer Immunotherapy
Yongjuan Li, Xinyan Li, Jinmeng Yi, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 19
Closed Access | Times Cited: 33
CD47 is a tumor cell-derived exosomal signature and regulates tumor immune microenvironment and immunotherapy responses
Yifei Luan, Yinghui Zhang, Shangjin Li, et al.
Translational Oncology (2025) Vol. 53, pp. 102291-102291
Open Access | Times Cited: 1
Generation of Myeloid Cells in Cancer: The Spleen Matters
Chong Wu, Qiaomin Hua, Limin Zheng
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 62
An Adjuvant Micelle-Based Multifunctional Nanosystem for Tumor Immunotherapy by Remodeling Three Types of Immunosuppressive Cells
Siyu Meng, Huiping Du, Xiang Li, et al.
ACS Nano (2024) Vol. 18, Iss. 4, pp. 3134-3150
Closed Access | Times Cited: 7
Advances in nano-immunotherapy for hematological malignancies
Jian Xu, Wenqi Liu, Fengjuan Fan, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Nano-immunotherapy for each stage of cancer cellular immunity: which, why, and what?
Shiyi Zuo, Jiaxuan Song, Jingxuan Zhang, et al.
Theranostics (2021) Vol. 11, Iss. 15, pp. 7471-7487
Open Access | Times Cited: 39
Second near-infrared photothermal-amplified immunotherapy using photoactivatable composite nanostimulators
Haitao Sun, Tianzhu Yu, Xin Li, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 36
Recent advances in nanoparticles-based photothermal therapy synergizing with immune checkpoint blockade therapy
Xinlun Dai, Xin Li, Yahui Liu, et al.
Materials & Design (2022) Vol. 217, pp. 110656-110656
Open Access | Times Cited: 25
Nanotechnology-based multifunctional vaccines for cancer immunotherapy
Xiaoxue Xie, Ting Song, Yi Feng, et al.
Chemical Engineering Journal (2022) Vol. 437, pp. 135505-135505
Closed Access | Times Cited: 23
Engineering TGF-β inhibitor-encapsulated macrophage-inspired multi-functional nanoparticles for combination cancer immunotherapy
Jae‐Hyun Kim, Minjeong Kim, Seok‐Beom Yong, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 14
Curdlan, zymosan and a yeast-derived β-glucan reshape tumor-associated macrophages into producers of inflammatory chemo-attractants
Priscilla de Graaff, Cor Berrevoets, Christiane Rösch, et al.
Cancer Immunology Immunotherapy (2020) Vol. 70, Iss. 2, pp. 547-561
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top